Abstract
Plasma levels of immunoreactive insulin (IRI), C-peptide and glucagon were assayed in 16 patients with liver cirrhosis and 9 control subjects after an oral glucose load (OGTT). Nine of the cirrhotics showed glucose intolerance, the remaining 7 cases showed normal OGTT. Both groups of cirrhotics showed high IRI and C-peptide values in basal conditions; peaks of these parameters, higher than those observed in the control subjects, were found during the OGTT. The C-peptide/IRI ratio, which was lower than normal both during fasting and after glucose load, presented the lowest values in patients with normal OGTT. In the conditions adopted for this study, glucagon showed higher plasma levels in all the cirrhotics studied than those found in the controls, but the highest levels were found in patients with normal OGTT. It can be concluded that the high levels of insulin found in liver cirrhosis are due to a β-pancreatic hypersecretion (high C-peptide levels) but are also maintained by a decreased hepatic degradation of the hormone (C-peptide/IRI ratio below normal). Hyperglucagonemia is not the chief factor in determining the insulin-resistance observed in liver cirrhosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Guillon J., Cha bonnel B. Diabète secondaire aux maladies du foie. Diabète et Metabolisme 1: 191, 1975.
Podolsky S., Zimmerman H.J., Burrows B.A., Cardarelli J.A., Pattavina C.G. Potassium depletion in cirrhosis: impaired GH and insulin response. N. Engl. J. Med. 288: 644, 1973.
Gragnoli G., Pupillo A., Montagnani M., Bayeli F.P. Alterazioni del metabolismo glicido, Nefa plasmatici e insulina immuno-reattiva nella cirrosi epatica. Atti Accad. Fisiocr. Siena 17: 1373, 1968.
Conn H.O., Daughaday W.H. Serum human growth hormone levels in Laennec’s cirrhosis. J. Lab. Clin. Med. 76: 678, 1970.
Marco J., Diego J., Villanueva L., Segovia J.M. Elevated plasma glucagon levels in cirrhosis of the liver. N. Engl. J. Med. 289: 1107, 1973.
Horwitz D.L., Starr J.I., Mako M.E., Blackard W.G., Rubenstein A.H. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J. Clin. Invest. 55: 1278, 1975.
Johnston D.G., Alberti K.G.M.M., Faber O.K., Binder C., Wright R. Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion? Lancet 1: 10, 1977.
Kawai K., Hayakawa H., Yoshida K., Shimizu M., Noto Y., Ohno T., Morita N., Hattori N. Plasma insulin and C-peptide levels in cirrhotic and uremic patients. Diabète et Metabolisme 3: 7, 1977.
Iwasaki Y., Ohkubo A., Kajinuma H., Akanuma Y., Kosaka K. Degradation and secretion of insulin in hepatic cirrhosis. J. Clin. Endocrinol. Metab. 47: 774, 1978.
Report of the committee on statistics of the American Diabetes Association. Standardization of the oral glucose tolerance test. Diabetes 18: 299, 1969.
Trinder P. Determination of glucose in blood using glucose-oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6: 24,1969.
Hales C.N., Randle P.J. Immunoassay of insulin with insulin-antibody precipitate. Biochem. J. 88: 137, 1963.
Heding L.G. Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541, 1975.
Faloona G.R., Unger R.H. Methods of hormone radioimmunoassay. In: Jaffe B.M., Behrman H.R. (Eds.), Glucagon. Academic Press, New York, 1974, p. 317.
Unger R.H., Eisentraut A.M., McCall M.S., Madison L.L. Measurement of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. J. Clin. Invest. 41: 682, 1962.
Aguilar-Parada E., Eisentraut A.M., Unger R.H. Pancreatic glucagon secretion in normal and diabetic subjects. Am. J. Med, Sci. 257: 415, 1969.
Felig P., Brown W.V., Levine R.A., Klatskin G. Glucose homeostasis in viral hepatitis. N. Engl. J. Med. 283: 1436, 1970.
Sherwin R.S., Fisher M., Bessoff J., Snyder Ned., Hendler R., Conn H.O., Felig P. Hyperglucagonemia in cirrhosis: altered secretion and sensivity to glucagon. Gastroenterology 74: 1224, 1978.
Bertoli A., Manna R., Rebuzzi A.G., Altomonte L., Ghirlanda G., Greco A.V. I recettori insulinici nella cirrosi epatica. Atti 7° Congresso Società Italiana Diabetologia, Ferrara 25–27 maggio 1978, abstract no. 122.
Freychet P. Récepteurs de l’insuline. Diabète et Metabolisme 1: 57, 1975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gragnoli, G., Signorini, A.M. & Tanganelli, I. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis. J Endocrinol Invest 4, 1–5 (1981). https://doi.org/10.1007/BF03349405
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349405